Viewing Study NCT02216669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:00 PM
Ignite Modification Date: 2026-02-25 @ 4:49 PM
Study NCT ID: NCT02216669
Status: WITHDRAWN
Last Update Posted: 2017-03-03
First Post: 2014-08-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer
Sponsor: Maastricht Radiation Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
None Head and Neck Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid tumors View
None Head and Neck Neoplasms View